NASDAQ:ARNA
Delisted
Arena Pharmaceuticals Stock News
$99.99
+0 (+0%)
At Close: May 27, 2022
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Shares Purchased by BNP Paribas Arbitrage SA
07:04am, Sunday, 14'th Jun 2020
BNP Paribas Arbitrage SA lifted its holdings in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 119.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange C
Arena Pharmaceuticals Announces R&D Leadership Transition
08:30pm, Monday, 08'th Jun 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced changes to its research and development leadership team. Effective June 9, 2020, Dr. Preston Klassen will be leaving the Company to pursue an
Edited Transcript of ARNA earnings conference call or presentation 7-May-20 8:30pm GMT
05:28pm, Monday, 08'th Jun 2020
Q1 2020 Arena Pharmaceuticals Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs June 3)
Arena Pharmaceuticals, Inc. (...
Hedge Funds Aren’t Done Buying Arena Pharmaceuticals, Inc. (ARNA)
05:13am, Wednesday, 03'rd Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and determine whether it is a good investment right now. We at Insider Monke
6 Stocks To Watch: Arena Pharma, Baozun, NIO, Precigen, Sea Limited, Stratasys
12:00am, Wednesday, 03'rd Jun 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Extreme Networks Inc, DXC Technology Co, Compugen. Read Harry Boxer's latest article on Investing.com
Why Bristol Myers' Success In Ulcerative Colitis Sent Arena Stock Flying
08:23pm, Tuesday, 02'nd Jun 2020
Bristol Myers Squibb reported positive ulcerative colitis treatment data Tuesday helping shares of rival Arena Pharmaceuticals to pop. Arena is testing a similar drug called etrasimod.
Hedge Funds Aren’t Done Buying Arena Pharmaceuticals, Inc. (ARNA)
07:13pm, Tuesday, 02'nd Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and determine whether it is a good investment right now. We at Insider Monke
Here's Why Arena Pharmaceuticals Jumped Higher Today
06:59pm, Tuesday, 02'nd Jun 2020
Shares of Arena Pharmaceuticals (NASDAQ: ARNA) are up 13% at 2:13 p.m. EDT because its rival, Bristol Myers Squibb (NYSE: BMY), reported positive data on Zeposia in patients with ulcerative colitis.
